THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE

Herrlinger, U. and Schaefer, N. and Steinbach, J. P. and Weyerbrock, A. and Hau, P. and Goldbrunner, R. and Leutgeb, B. and Urbach, H. and Stummer, W. and Glas, M. (2014) THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: FINAL SURVIVAL RESULTS AND QUALITY OF LIFE. NEURO-ONCOLOGY, 16 (Suppl2): O10.04. ii23-ii24. ISSN 1522-8517, 1523-5866

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)
Depositing User: Petra Gürster
Date Deposited: 06 Aug 2020 12:05
Last Modified: 06 Aug 2020 12:05
URI: https://pred.uni-regensburg.de/id/eprint/9602

Actions (login required)

View Item View Item